MedPath

To evaluate effect of Tiladi Kwatha Orally & Shatpushpa Siddha Taila Nasya in the treatment of Pushpaghni (PCOS)

Phase 2
Conditions
Health Condition 1: E282- Polycystic ovarian syndrome
Registration Number
CTRI/2023/08/055952
Lead Sponsor
Post Graduate Institute of Ayurved, Jodhpur Rajasthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients diagnosed cases of PCOS by the Rotterdam criteria.

2.Age: Patients aged between 16-40 years.

3. The patients who are fit for the Nasya procedure were only considered for the study.

4. Patients willing for Informed consent.

Exclusion Criteria

•Patients having any other disease causing oligomenorrhea and anovulation excluding PCOD on the above criteria.

•Patients using oral contraceptive pills.

•Pregnant and lactating women.

•Patients suffering from thyroid abnormalities, Hyperprolactinemia, adrenal hyperplasia etc.

•Patients with any organic reproductive system abnormalities like hydrosalpinx, endometriosis, fibroid uterus, carcinoma of reproductive organ and sexually transmitted disease (STDs), Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antigen (HBsAg).

•Systemic disorders like-uncontrolled diabetes mellitus, chronic liver disease, renal disorder, Uncontrolled hypertension, Diagnosed case of any type of malignancy.

•Patients who are contraindicated for Nasya like, Nasal polyp etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Assessment for Menstrual abnormality (Oligomenorrhea) <br/ ><br>2.Assessment for Hypomenorrhea <br/ ><br>3.Assessment for Menorrhagia <br/ ><br>4.Pain associated with Menstruation <br/ ><br>5.Assessment of Acne (according to acne grading) <br/ ><br>6.Assessment of Hirsutism (on the basis of site) <br/ ><br>Timepoint: for 8 weeks
Secondary Outcome Measures
NameTimeMethod
â?¢Percentage improvement in reduction of ovarian size, volume, stromal pattern <br/ ><br>â?¢Percentage improvement in biochemical values. <br/ ><br>â?¢Percentage improvement in hormonal assays. <br/ ><br>â?¢Weight reduction as assessed by reduction in Body weight, BMITimepoint: 60 DAYS
© Copyright 2025. All Rights Reserved by MedPath